vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.
IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 4.8%, a 3.4% gap on every dollar of revenue. On growth, IPG PHOTONICS CORP posted the faster year-over-year revenue change (17.1% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $10.9M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 4.4%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
COLL vs IPGP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $274.5M |
| Net Profit | $17.0M | $13.3M |
| Gross Margin | 62.5% | 36.1% |
| Operating Margin | 29.6% | 1.2% |
| Net Margin | 8.3% | 4.8% |
| Revenue YoY | 12.9% | 17.1% |
| Net Profit YoY | 35.3% | 69.8% |
| EPS (diluted) | $0.48 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $274.5M | ||
| Q3 25 | $209.4M | $250.8M | ||
| Q2 25 | $188.0M | $250.7M | ||
| Q1 25 | $177.8M | $227.8M | ||
| Q4 24 | $181.9M | $234.3M | ||
| Q3 24 | $159.3M | $233.1M | ||
| Q2 24 | $145.3M | $257.6M | ||
| Q1 24 | $144.9M | $252.0M |
| Q4 25 | $17.0M | $13.3M | ||
| Q3 25 | $31.5M | $7.5M | ||
| Q2 25 | $12.0M | $6.6M | ||
| Q1 25 | $2.4M | $3.8M | ||
| Q4 24 | $12.5M | $7.8M | ||
| Q3 24 | $9.3M | $-233.6M | ||
| Q2 24 | $19.6M | $20.2M | ||
| Q1 24 | $27.7M | $24.1M |
| Q4 25 | 62.5% | 36.1% | ||
| Q3 25 | 61.7% | 39.5% | ||
| Q2 25 | 57.7% | 37.3% | ||
| Q1 25 | 54.8% | 39.4% | ||
| Q4 24 | 54.0% | 38.6% | ||
| Q3 24 | 60.8% | 23.2% | ||
| Q2 24 | 62.5% | 37.3% | ||
| Q1 24 | 63.1% | 38.7% |
| Q4 25 | 29.6% | 1.2% | ||
| Q3 25 | 29.7% | 3.1% | ||
| Q2 25 | 18.7% | 0.0% | ||
| Q1 25 | 12.2% | 0.8% | ||
| Q4 24 | 20.9% | 6.0% | ||
| Q3 24 | 21.9% | -108.7% | ||
| Q2 24 | 32.7% | 4.7% | ||
| Q1 24 | 34.1% | 7.6% |
| Q4 25 | 8.3% | 4.8% | ||
| Q3 25 | 15.0% | 3.0% | ||
| Q2 25 | 6.4% | 2.6% | ||
| Q1 25 | 1.4% | 1.6% | ||
| Q4 24 | 6.9% | 3.3% | ||
| Q3 24 | 5.9% | -100.2% | ||
| Q2 24 | 13.5% | 7.8% | ||
| Q1 24 | 19.1% | 9.6% |
| Q4 25 | $0.48 | $0.30 | ||
| Q3 25 | $0.84 | $0.18 | ||
| Q2 25 | $0.34 | $0.16 | ||
| Q1 25 | $0.07 | $0.09 | ||
| Q4 24 | $0.36 | $0.27 | ||
| Q3 24 | $0.27 | $-5.33 | ||
| Q2 24 | $0.52 | $0.45 | ||
| Q1 24 | $0.71 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $839.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $2.1B |
| Total Assets | $1.7B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $839.3M | ||
| Q3 25 | $285.9M | $870.4M | ||
| Q2 25 | $222.2M | $899.6M | ||
| Q1 25 | $197.8M | $926.9M | ||
| Q4 24 | $162.8M | $930.2M | ||
| Q3 24 | $120.0M | $1.0B | ||
| Q2 24 | $271.6M | $1.1B | ||
| Q1 24 | $318.0M | $1.1B |
| Q4 25 | $301.7M | $2.1B | ||
| Q3 25 | $274.8M | $2.1B | ||
| Q2 25 | $232.2M | $2.1B | ||
| Q1 25 | $234.4M | $2.1B | ||
| Q4 24 | $228.8M | $2.0B | ||
| Q3 24 | $234.3M | $2.1B | ||
| Q2 24 | $216.6M | $2.3B | ||
| Q1 24 | $222.2M | $2.3B |
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.6B | $2.4B | ||
| Q2 25 | $1.6B | $2.4B | ||
| Q1 25 | $1.6B | $2.3B | ||
| Q4 24 | $1.7B | $2.3B | ||
| Q3 24 | $1.6B | $2.4B | ||
| Q2 24 | $1.1B | $2.5B | ||
| Q1 24 | $1.1B | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $28.8M |
| Free Cash FlowOCF − Capex | $122.4M | $10.9M |
| FCF MarginFCF / Revenue | 59.6% | 4.0% |
| Capex IntensityCapex / Revenue | 0.3% | 6.5% |
| Cash ConversionOCF / Net Profit | 7.25× | 2.17× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-3.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $28.8M | ||
| Q3 25 | $78.4M | $35.3M | ||
| Q2 25 | $72.4M | $-2.2M | ||
| Q1 25 | $55.4M | $13.4M | ||
| Q4 24 | $84.6M | $73.8M | ||
| Q3 24 | $-9.0M | $66.1M | ||
| Q2 24 | $67.4M | $53.5M | ||
| Q1 24 | $61.9M | $54.6M |
| Q4 25 | $122.4M | $10.9M | ||
| Q3 25 | $78.3M | $14.6M | ||
| Q2 25 | $72.4M | $-17.6M | ||
| Q1 25 | $54.6M | $-11.4M | ||
| Q4 24 | $84.1M | $50.6M | ||
| Q3 24 | $-9.2M | $43.0M | ||
| Q2 24 | $67.1M | $29.2M | ||
| Q1 24 | $61.4M | $26.5M |
| Q4 25 | 59.6% | 4.0% | ||
| Q3 25 | 37.4% | 5.8% | ||
| Q2 25 | 38.5% | -7.0% | ||
| Q1 25 | 30.7% | -5.0% | ||
| Q4 24 | 46.2% | 21.6% | ||
| Q3 24 | -5.8% | 18.4% | ||
| Q2 24 | 46.2% | 11.3% | ||
| Q1 24 | 42.3% | 10.5% |
| Q4 25 | 0.3% | 6.5% | ||
| Q3 25 | 0.1% | 8.3% | ||
| Q2 25 | 0.0% | 6.1% | ||
| Q1 25 | 0.4% | 10.9% | ||
| Q4 24 | 0.3% | 9.9% | ||
| Q3 24 | 0.2% | 9.9% | ||
| Q2 24 | 0.2% | 9.4% | ||
| Q1 24 | 0.4% | 11.1% |
| Q4 25 | 7.25× | 2.17× | ||
| Q3 25 | 2.49× | 4.73× | ||
| Q2 25 | 6.05× | -0.34× | ||
| Q1 25 | 22.92× | 3.58× | ||
| Q4 24 | 6.75× | 9.44× | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | 2.65× | ||
| Q1 24 | 2.23× | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
IPGP
| Materials Processing | $232.8M | 85% |
| Laser And Non Laser Systems | $38.8M | 14% |
| Transferred Over Time | $5.3M | 2% |
